VIM and autoimmune disease: In pathological conditions such as inflammation, tissue injury, or autoimmune disease, vimentin undergoes posttranslational modifications (PTMs) including phosphorylation and citrullination, which promote the disassembly of vimentin filaments into soluble oligomers.